Scarica l'app Stockscreener
5.07
2.22%
0.11
Precedente Chiudi:
$4.96
Aprire:
$4.8
Volume 24 ore:
104.33K
Relative Volume:
0.88
Capitalizzazione di mercato:
$253.32M
Reddito:
$15.33M
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-2.8935
EPS:
-1.7522
Flusso di cassa netto:
-
1 W Prestazione:
+11.18%
1M Prestazione:
-1.36%
6M Prestazione:
-6.80%
1 anno Prestazione:
+14.45%
Intervallo 1D:
$4.71
$5.10
Intervallo di 1 settimana:
$4.36
$5.10
Portata 52W:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Nome
Trisalus Life Sciences Inc
Settore
Industria
Telefono
415 336 8917
Indirizzo
6272 WEST 91ST AVENUE, WESTMINSTER
Confronta TLSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.07 | 247.82M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Iniziato | ROTH MKM | Buy |
| 2024-10-25 | Iniziato | Northland Capital | Outperform |
| 2024-09-16 | Iniziato | Oppenheimer | Outperform |
| 2024-05-30 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
TriSalus (TLSI) Q3 2025 Earnings Call Transcript - AOL.com
Why TriSalus Life Sciences Inc. Equity Warrant stock appeals to analystsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Why hedge funds are buying TriSalus Life Sciences Inc. Equity Warrant stockGap Up & Safe Swing Trade Setups - newser.com
Will TriSalus Life Sciences Inc. stock attract more institutional investorsTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Research Analysts Offer Predictions for TLSI FY2026 Earnings - Defense World
Can TriSalus Life Sciences Inc. Equity Warrant stock beat analyst upgradesJuly 2025 Levels & Real-Time Buy Signal Alerts - newser.com
Combining price and volume data for TriSalus Life Sciences Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock overvalued by current metricsJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Is TriSalus Life Sciences Inc. stock a dividend growth opportunity2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
How strong is TriSalus Life Sciences Inc. Equity Warrant stock revenue growthWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
TriSalus Life Sciences Inc. Equity Warrant stock volume spike explainedEarnings Recap Summary & Consistent Income Trade Recommendations - newser.com
Is TriSalus Life Sciences Inc. Equity Warrant stock attractive for long term wealth buildingJuly 2025 Retail & Verified Short-Term Plans - newser.com
Is now a turning point for TriSalus Life Sciences Inc. Equity WarrantVolume Spike & Daily Market Momentum Tracking - newser.com
What machine learning models say about TriSalus Life Sciences Inc.July 2025 Levels & Low Risk Entry Point Guides - newser.com
What high frequency data says about TriSalus Life Sciences Inc. Equity WarrantOil Prices & Capital Efficient Trading Techniques - newser.com
TriSalus Life Sciences Launches TriNav®? XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery?? - MarketScreener
What’s next for TriSalus Life Sciences Inc. stock priceBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Trisalus Life Sciences launches Trinav® XP infusion system to expand options for pressure-enabled drug delivery - MarketScreener
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Eagle-Tribune
Waystar Holding Corp. (Nasdaq: WAY) Added to S&P SmallCap 600, Handles $1.8T Claims - Stock Titan
Custom strategy builders for tracking TriSalus Life Sciences Inc.Trend Reversal & Trade Opportunity Analysis - newser.com
Can machine learning forecast TriSalus Life Sciences Inc. Equity Warrant recoveryMarket Volume Report & Growth Focused Investment Plans - newser.com
TriSalus reaffirms 50% revenue growth target while advancing TriNav platform and product launches - MSN
Will TriSalus Life Sciences Inc. stock gain from government policies2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
How TriSalus Life Sciences Inc. stock performs in stagflationEarnings Growth Summary & Stock Portfolio Risk Control - newser.com
Automated trading signals detected on TriSalus Life Sciences Inc.July 2025 Trends & Safe Capital Growth Plans - newser.com
Trisalus Life Sciences Reports Strong Earnings Amid Challenges - MSN
Has TriSalus Life Sciences Inc. formed a bullish divergenceJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Real time social sentiment graph for TriSalus Life Sciences Inc.Share Buyback & Stock Portfolio Risk Management - newser.com
Trisalus Life Sciences Inc Azioni (TLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):